Non-scheduled short-acting opioid to taper off opioids?

This article also proposes to develop short-acting opioids for addiction management instead of the current long-acting regimen. The authors further suggest that dezocine, a previously FDA approved medication for perioperative pain management and a non-scheduled opioid, be brought back to clinical practice in the US as a potential alternative addiction management medication, especially for those who are highly motivated to quit opioids completely using a taper off strategy.PMID:38584343 | DOI:10.1111/cns.14705
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Source Type: research